Champions Oncology Inc
SWB:2I3
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Champions Oncology Inc
SWB:2I3
|
US |
|
D
|
Diversified Healthcare Trust
SWB:SNF
|
US |
|
E
|
Eramet SA
XMUN:ER7
|
FR |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 2I3's stock price target?
Not Available
2I3 does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Champions Oncology Inc?
Projected CAGR
22%
Over the last 14 years, the compound annual growth rate for Revenue has been 16%. The projected CAGR for the next 4 years is 22%.
What is the Gross Profit forecast for Champions Oncology Inc?
Projected CAGR
-5%
Over the last 14 years, the compound annual growth rate for Gross Profit has been 20%. The projected CAGR for the next 1 year is -5%.